Legal Analysis - Scrip Regulatory Affairs
14 October 2011
Everyday counts: why pharmaceutical companies in the EU need to make sure they get the right SPC term
Pharmaceutical companies using the centralised authorisation procedure in the EU may be entitled to a slightly longer supplementary certificate procedure term than they might think, says Mike Snodin.
This article appeared in the October issue of Scrip Regulatory Affairs